Cohen & Steers (CNS): Director Granted 423 RSUs, 1,302 Shares Owned

Karen Wilson Thissen, a director of Cohen & Steers, Inc. (CNS), received an award of 423 restricted stock units on 10/01/2025.

Rhea-AI Filing Summary

Karen Wilson Thissen, a director of Cohen & Steers, Inc. (CNS), received an award of 423 restricted stock units on 10/01/2025. The filing shows the RSUs were 100% vested on the grant date and will be delivered in shares to Ms. Thissen Wilson on the third anniversary of the grant. The Form 4 reports an acquisition price of $0 for the award and that the reporting person beneficially owns 1,302 shares of common stock following the transaction. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• 423 RSUs granted to a director, aligning compensation with shareholder interests
• 100% vested on grant date, indicating no further service condition to vesting

Negative

• Delivery deferred until the third anniversary, delaying actual share receipt and liquidity

Insights

Corporate Governance Expert

Director received 423 RSUs, vested on grant with delivery delayed three years.

The Form 4 discloses a grant of 423 restricted stock units to Karen Wilson Thissen on 10/01/2025 that were 100% vested at grant but are contractually payable on the third anniversary of the grant date.

Because the RSUs carry an acquisition price of $0 and add to the director's total beneficial ownership of 1,302 shares, the award aligns executive compensation with shareholder exposure while preserving a retention/timing element via delayed delivery.

Insider Trade Summary

Grant/Award: 423 shares

Grant/Award 1 txn

Insider THISSEN KAREN WILSON

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	423	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,302 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

FAQ

What did the Form 4 for Cohen & Steers (CNS) disclose?

The Form 4 shows director Karen Wilson Thissen was granted 423 restricted stock units on 10/01/2025 and beneficially owns 1,302 common shares.

Were the RSUs immediately vested for Karen Thissen Wilson?

Yes. The filing states the restricted stock units were 100% vested on the grant date.

When will the RSUs be delivered as shares?

The related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

What price was paid for the RSU award?

The transaction is reported with an acquisition price of $0, consistent with a grant of RSUs.

Who signed the Form 4 filing?

The filing bears the signature of Brian W. Heller, Attorney-in-Fact dated 10/03/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 08:04 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

THISSEN KAREN WILSON

(Last) (First) (Middle)

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A		423(1)	A	$0	1,302	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Remarks:

	/s/ Brian W. Heller, Attorney-in-Fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.